Protein misfolding, aggregation, and degradation in disease

56Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Pathologies associated with protein misfolding have been observed in neurodegenerative diseases such as Alzheimer's disease, metabolic diseases like phenylketonuria, and diseases affecting structural proteins like collagen or keratin. Misfolding of mutant proteins in these and many other diseases may result in premature degradation, formation of toxic aggregates, or incorporation of toxic conformations into structures. We review common traits of these diverse diseases under the unifying view of protein misfolding. The molecular pathogenesis is discussed in the context of protein quality control systems consisting of molecular chaperones and intracellular proteases that assist the folding and supervise the maintenance of the folded structure. Furthermore, genetic and environmental factors that may modify the severity of these diseases are underscored. © 2005 Humana Press Inc. All rights of any nature whatsoever reserved.

Cite

CITATION STYLE

APA

Gregersen, N., Bolund, L., & Bross, P. (2005, October). Protein misfolding, aggregation, and degradation in disease. Molecular Biotechnology. https://doi.org/10.1385/MB:31:2:141

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free